Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,560.55
51.25 (2.04%)
BSENSE

Dec 05

BSE+NSE Vol: 1.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
979.94
805.17
974.37
949.42
1,010.77
814.65
929.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
979.94
805.17
974.37
949.42
1,010.77
814.65
929.80
Raw Material Cost
115.13
128.06
115.23
97.48
148.96
138.23
204.60
Purchase of Finished goods
232.72
232.06
291.40
164.23
216.74
172.74
255.74
(Increase) / Decrease In Stocks
7.68
-72.41
-54.69
97.45
18.79
-15.70
-93.21
Employee Cost
138.05
152.57
152.97
124.74
150.71
151.28
172.83
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
150.63
113.69
136.27
173.60
153.86
137.56
132.58
Total Expenditure (Excl Depreciation)
644.21
553.97
641.18
657.50
689.06
584.11
672.54
Operating Profit (PBDIT) excl Other Income
335.73
251.20
333.19
291.92
321.71
230.54
257.26
Other Income
33.57
43.72
40.68
35.07
34.54
35.64
29.83
Operating Profit (PBDIT)
369.30
294.92
373.87
326.99
356.25
266.18
287.09
Interest
0.51
0.42
0.58
0.09
0.27
0.37
0.77
Exceptional Items
2.64
0.00
0.00
0.00
4.69
0.00
2.40
Gross Profit (PBDT)
371.43
294.50
373.29
326.90
360.67
265.81
288.72
Depreciation
17.43
15.52
14.72
18.80
16.86
16.41
18.10
Profit Before Tax
354.00
278.98
358.57
308.10
343.81
249.40
270.62
Tax
96.51
73.97
95.70
78.22
91.31
67.07
76.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
257.49
205.01
262.87
229.88
252.50
182.33
194.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
257.49
205.01
262.87
229.88
252.50
182.33
194.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
257.49
205.01
262.87
229.88
252.50
182.33
194.48
Equity Capital
169.41
169.41
169.41
169.41
169.41
169.41
169.41
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
15.2
12.1
15.52
13.57
14.9
10.76
11.48
Diluted Earnings per share
15.02
12.1
15.52
13.57
14.91
10.76
11.48
Operating Profit Margin (Excl OI)
34.26%
31.2%
34.2%
30.75%
31.83%
28.3%
27.67%
Gross Profit Margin
37.9%
36.58%
38.31%
34.43%
35.68%
32.63%
31.05%
PAT Margin
26.28%
25.46%
26.98%
24.21%
24.98%
22.38%
20.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 21.71% vs -17.37% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 25.60% vs -22.01% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 33.65% vs -24.61% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 21.43% vs -27.59% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Glaxosmi. Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
979.94
4,295.50
-3,315.56
-77.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
979.94
4,295.50
-3,315.56
-77.19%
Raw Material Cost
115.13
1,367.50
-1,252.37
-91.58%
Purchase of Finished goods
232.72
135.00
97.72
72.39%
(Increase) / Decrease In Stocks
7.68
44.50
-36.82
-82.74%
Employee Cost
138.05
887.70
-749.65
-84.45%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
150.63
1,025.40
-874.77
-85.31%
Total Expenditure (Excl Depreciation)
644.21
3,460.10
-2,815.89
-81.38%
Operating Profit (PBDIT) excl Other Income
335.73
835.40
-499.67
-59.81%
Other Income
33.57
93.00
-59.43
-63.90%
Operating Profit (PBDIT)
369.30
928.40
-559.10
-60.22%
Interest
0.51
272.20
-271.69
-99.81%
Exceptional Items
2.64
-11.90
14.54
122.18%
Gross Profit (PBDT)
371.43
644.30
-272.87
-42.35%
Depreciation
17.43
473.00
-455.57
-96.32%
Profit Before Tax
354.00
171.30
182.70
106.65%
Tax
96.51
38.50
58.01
150.68%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
257.49
132.80
124.69
93.89%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
257.49
132.80
124.69
93.89%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
48.30
-48.30
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
257.49
84.50
172.99
204.72%
Equity Capital
169.41
668.50
-499.09
-74.66%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
15.20
0.63
14.57
2,312.70%
Diluted Earnings per share
15.02
0.65
14.37
2,210.77%
Operating Profit Margin (Excl OI)
34.26%
19.60%
0.00
14.66%
Gross Profit Margin
37.90%
15.12%
0.00
22.78%
PAT Margin
26.28%
3.12%
0.00
23.16%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 979.94 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 21.71% vs -17.37% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -3.05% vs 5.62% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 257.49 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 25.60% vs -22.01% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 1.98% vs 16.09% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 335.73 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 33.65% vs -24.61% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 4.36% vs 11.13% in Sep 2024

Quarterly - Interest
Interest 0.51 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 21.43% vs -27.59% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 88.89% vs -37.21% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.26%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024